Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

ETHZilla Corporation Warrant ATNFW NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score
42/100
2/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

ETHZilla Corporation Warrant (ATNFW) is a Medical - Pharmaceuticals company in the Healthcare sector, currently trading at $0.43. It has a SharesGrow Score of 38/100, indicating a weak investment profile with 2 out of 7 criteria passed.

Net income is $6M (loss), growing at +9%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $154,505 against $9M equity (Debt-to-Equity (D/E) ratio 0.02, conservative). Current ratio is 1.47 (adequate). Debt-to-assets is 1.2%. Total assets: $13M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 65/100 (Pass), Past 0/100 (Fail), Health 75/100 (Pass), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

ATNFW SharesGrow Score Overview

56/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 65/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 75/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ATNFW

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✓
GROWTH Pass
65/100
ATNFW: +0%/yr revenue is, +9%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✓
HEALTH Pass
75/100
Balance sheet ATNFW: Debt-to-Equity (D/E) ratio 0.02 (conservative), Current ratio is 1.47 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
ATNFW: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.36-0.4433
Volume1.62M
Avg Volume (30D)404.02K
Market Cap$2.6M
Beta (1Y)0.41
Share Statistics
EPS (TTM)-6.74
Shares Outstanding$915.37K
IPO Date2017-06-27
Employees4
CEOLloyd Blair Jordan
Financial Highlights & Ratios
EBITDA$-6.32M
Net Income$-6.17M
Operating Income$-6.32M
Total Cash$4.59M
Total Debt$154.51K
Net Debt$-4.43M
Total Assets$12.76M
Price / Earnings (P/E)-0.1
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS68236V1127

Price Chart

Track all markets on TradingView
ATNFW
ETHZilla Corporation Warrant ↗  ·  NASDAQ Capital Marke
Healthcare • Medical - Pharmaceuticals
0.36 52WK RANGE 0.44

People Also View

ATNF
ATNF
180 Life Sciences Corp.
$7.04
-7.49%
 RVPHW
RVPHW
Reviva Pharmaceuticals Holdings, Inc.
$0.00
-16.67%
 ARTLW
ARTLW
Artelo Biosciences, Inc.
$0.01
+0.00%
 ADILW
ADILW
Adial Pharmaceuticals, Inc. WT EXP 073123
$0.00
-57.14%
 ENTXW
ENTXW
Entera Bio Ltd. WT EXP 062723
$0.00
-60.00%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message